Acolysis During Treatment of Lesions Affecting Saphenous Vein Bypass Grafts - ATLAS - SVG

Description:

The goal of the Acolysis During Treatment of Lesions Affecting Saphenous Vein Bypass Grafts (ATLAS) trial was to compare the effect of acolysis (therapeutic ultrasound) versus abciximab in patients with saphenous vein grafts (SVGs) undergoing vein graft intervention.